<DOC>
	<DOCNO>NCT02120170</DOCNO>
	<brief_summary>There limited evidence bleed complication colon polypectomy patient take warfarin . This study aim analyse effect prophylactic hemo-clipping colon polypectomy patient warfarin consumption . The enrolled subject patient take warfarin high thromboembolism risk take heparin bridge therapy colon polypectomy instead temporary stop warfarin . The investigator randomize two group ; patient enrol group 1 perform hemoclipping polypectomy lesion irrespective presence immediate bleeding . And patient enrol group 2 perform hemoclipping lesion immediate bleeding colon polypectomy . The primary endpoint compare rate delay bleed two group .</brief_summary>
	<brief_title>Prophylactic Clip Application Colon Polypectomy Patients With Anticoagulation</brief_title>
	<detailed_description>The American guideline recommend patient low risk thromboembolism , warfarin consumption quit 3~5 day colon polypectomy resume within 24 hour polypectomy . However , patient high risk thromboembolism , patient take heparin bridging therapy temporal quit warfarin consumption colon polypectomy . There limited evidence bleed complication colon polypectomy patient warfarin take . Moreover , lack evidence prevent bleed complication patient high risk thromboembolism take heparin bridge therapy temporal stop warfarin colon polypectomy . This study aim analyse effect prophylactic hemo-clipping colon polypectomy patient warfarin consumption . The investigator enroll subject take heparin bridging therapy ( quit warfarin 3~5 day colon polypectomy check INR , INR &lt; 2 , heparin low molecular heparin start . If INR &lt; 1.5 day colon polypectomy , patient undergo bowel preparation colon polypectomy . Warfarin resume within 24 hour polypectomy ) quit warfarin colon polypectomy 19 year old . Exclusions follow ; patient n't take bridge heparin therapy quit warfarin , patient low platelet count ( &lt; 80,000/mm3 ) , patient take anti-platelet agent , patient GI malignancy . The investigator randomize two group ; patient enrol group 1 perform hemoclipping polypectomy lesion irrespective presence immediate bleeding . And patient enrol group 2 perform hemoclipping lesion immediate bleeding colon polypectomy . Including polyps colon polypectomy 6~ 20 mm size polypectomy procedure define EMR injection blend electrical current . The lesion immediate bleeding occur polypectomy perform hemoclipping irrespective group count delay bleed even though delayed bleeding occur lesion . The primary endpoint compare rate delay bleed two group . The secondary endpoint analyse effect hemoclipping immediate bleeding . This study perform 3 year 1st patient enrollment target size enrollment 356 ( 176 group ) .</detailed_description>
	<criteria>subject take heparin bridge therapy quit warfarin 3~5 day colon polypectomy high risk thromboembolism AF valvular disease , AF mechanical valve , AF CHF , EF &lt; 35 % , AF previous thromboembolism , AF DM HTN , AF old age ( &gt; 75 ) , patient n't take bridge heparin therapy quit warfarin , patient low platelet count ( &lt; 80,000/mm3 ) , patient take antiplatelet agent , patient GI malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Hemoclip , Heparin bridge therapy , colon polypectomy , warfarin</keyword>
</DOC>